Nonconjugate adaptation of human saccades to anisometropic spectacles: Meridianspecificity

H. Lemij,H. Collewijn

DOI: https://doi.org/10.1016/0042-6989(92)90237-D

IF: 1.8

1992-03-01

Vision Research

Abstract:

What problem does this paper attempt to address?

Effect of endodontic cement on bone mineral density using serial dual-energy x-ray absorptiometry.

M. Saghiri,J. Orangi,N. Tanideh,K. Janghorban,N. Sheibani

DOI: https://doi.org/10.1016/j.joen.2013.11.025

IF: 4.422

2014-05-01

Journal of Endodontics

Abstract:
Quality management in blood establishments

T. Vuk

DOI: https://doi.org/10.1111/j.1751-2824.2009.01212.x

2009-03-01

ISBT Science Series

Abstract:Transfusion medicine has a specific position relative to other fields of medical science. A series of laboratory and clinical medicine activities and pharmaceutical‐like manufacture, with tight interaction of various professionals are involved in the complex chain of transfusion medicine, from the promotion of blood donation through the utilization of blood products. Maintaining constant high quality and safety of the products and services required by blood donors, patients and public at large are the prime and foremost goals to be pursued in transfusion medicine. These supreme goals can only be achieved through efficient quality management in all segments and with due support from all those involved in this complex system. Recognizing quality as a necessity, transfusion services all over the world have introduced or are just being introducing quality management systems according to particular standards and regulations. In EU countries, quality management in blood establishments is legal obligation defined by the 2005/62/EC Directive. Only a comprehensive and integrated quality management system can guarantee quality in a continuous way. Standard requirements and specifications of such an integrated system based on GMP and ISO 9000 series standards are elaborated in this paper.
Blood and Blood Components: From Similarities to Differences

Olivier Garraud,Jean-Daniel Tissot

DOI: https://doi.org/10.3389/fmed.2018.00084

IF: 3.9

2018-04-09

Frontiers in Medicine

Abstract:Blood transfusion is made possible because, in most countries and organizations, altruistic individuals voluntarily, anonymously, and generously donate (without compensation) either whole blood or separated components that are then processed and distributed by professionals, prior to being allocated to recipients in need. Being part of modern medicine, blood transfusion uses so-called standard blood components when relative to cellular fractions and fresh plasma. However, as will be discussed in this paper, strictly speaking, such so-called labile blood components are not completely standard. Furthermore, the prevalent system based on voluntary, non-remunerated blood donation is not yet universal and, despite claims by the World Health Organization that 100% of blood collection will be derived from altruistic donations by 2020 (postponed to 2025), many obstacles may hinder this ambition, especially when relative to the collection of the enormous amount of plasma destined for fractionation into plasma derivative or drugs. Finally, country organizations also vary due to the economy, sociology, politics, and epidemiology. This paper then, discusses the particulars (of which ethical considerations) of blood transfusion diversity and the consequences for donors, patients, and society.

medicine, general & internal
Transfusion in limited infrastructure locations – where to go decades after safe blood initiative by World Health Organization?

Angela Ugwu,Dalha Gwarzo,Theresa Nwagha,Aisha Gwarzo,Andreas Greinacher

DOI: https://doi.org/10.1111/voxs.12519

2019-09-06

ISBT Science Series

Abstract:Transfusion demand in sub‐Saharan Africa is increasing. Establishment of large national blood services seems to be challenging. Hospital blood services maintain the basic supply. However, they lack effective communication networks. Cell phones/internet provides the infrastructure for establishing such networks and could help in establishing haemovigilance systems. Voluntary non‐remunerated donors are the minority of donors (<20%). It seems more appropriate to develop strategies to increase the safety of replacement donor blood instead of insisting on copying Western‐world models. Red cell serology is usually restricted to ABO/Rh‐D and at best Coombs crossmatch. Introduction of antibody differentiation and additional typing for C,c,E,e and K would prevent 60–70% of delayed haemolytic transfusion reactions. One of the most frequent indications for blood transfusion is major haemorrhage. Why is component therapy still recommended for resource‐limited regions, while whole blood is reintroduced in Europe/US for exactly the same indications? Plasma thawed due to electricity failures is usually discarded anyway. Leuco‐depleted products would be beneficial (multitransfused sickle‐cell patients/neonates/AIDS). An ideal blood product could be whole blood, in‐line leuco reduced by gravity filtration, treated by user‐friendly pathogen‐reduction not requiring irradiation/illumination. The transfusion medicine community should form an alliance to develop an affordable, pathogen‐reduced blood product, to train regional auditors and to bring in external expertise to aid knowledge transfer. However, standards to be reached should be defined by the respective national experts who understand the culture and needs of their country. In respectful collaboration, we could learn from each other to finally improve transfusion in resource‐limited regions.
Quality Assessment of Established and Emerging Blood Components for Transfusion

Jason P. Acker,Denese C. Marks,William P. Sheffield

DOI: https://doi.org/10.1155/2016/4860284

2016-12-14

Journal of Blood Transfusion

Abstract:Blood is donated either as whole blood, with subsequent component processing, or through the use of apheresis devices that extract one or more components and return the rest of the donation to the donor. Blood component therapy supplanted whole blood transfusion in industrialized countries in the middle of the twentieth century and remains the standard of care for the majority of patients receiving a transfusion. Traditionally, blood has been processed into three main blood products: red blood cell concentrates; platelet concentrates; and transfusable plasma. Ensuring that these products are of high quality and that they deliver their intended benefits to patients throughout their shelf-life is a complex task. Further complexity has been added with the development of products stored under nonstandard conditions or subjected to additional manufacturing steps (e.g., cryopreserved platelets, irradiated red cells, and lyophilized plasma). Here we review established and emerging methodologies for assessing blood product quality and address controversies and uncertainties in this thriving and active field of investigation.
Roles of thyroid, adrenal and pancreatic hormones on thyroid activity of the soft-shelled turtles Lissemys punctata punctata Bonnoterre.

P. P. Ray,S. Sarkar,A. Sengupta,S. Chaudhuri-Sengupta,B. Maiti

DOI: https://doi.org/10.3409/173491606778557527

Folia biologica

Abstract:The effects of some exogenous peripheral hormones (thyroxine, corticosterone, epinephrine, norepinephrine and insulin) on thyroid activity were investigated in juvenile female soft-shelled turtles, Lissemys punctata punctata. Each hormone was injected in three different doses (25 microg, 50 microg or 100 microg each per 100 g body weight, once daily at 9 AM) for 10 consecutive days. Thyroid activity was evaluated by gravimetry, histology (epithelial height) and thyroperoxidase assay. The findings revealed that thyroxine in low dose (25 microg) stimulated thyroid activity by increasing the relative thyroid weight, epithelial height and thyroperoxidase activity, but inhibited gland activity at a high dose (100 microg) by decreasing the values of all these parameters. The medium dose (50 microg) had no significant effect. All other hormones, in all doses, significantly decreased thyroid activity by decreasing the values of all the parameters. Thyroid responses to exogenous hormones are generally dose-dependent in turtles. The mechanisms of actions of the hormones administered are suggested.
Comparison of inhibitory effects of warfarin on gamma-carboxylation between bone and liver in rats.

K. Hara,Masatoshi Kobayashi,Y. Akiyama

Journal of Bone and Mineral Metabolism

Abstract:The purposes of this study were to clarify that warfarin (WF, vitamin K antagonist) levels that inhibit gamma-carboxylation are different in liver and bone (experiment 1), and to investigate whether the plasma osteocalcin (OC) level reflects bone OC levels (experiments 2 and 3). Four-week-old male rats were treated with 0.2, 0.4, 0.6, 0.8, 1.0, or 1.2 mg/l of WF solution as drinking water for 4 weeks. Blood coagulation activity, an index of gamma-carboxylation of prothrombin in the liver, was significantly decreased in rats receiving 0.8 mg/l or larger doses of WF. A significant decrease of plasma gamma-carboxylated OC (GlaOC), an index of gamma-carboxylation of OC in bone, was shown in rats receiving 0.2 mg/l or larger doses. Significantly lower OC levels in the femoral diaphysis and metaphysis were shown in the 0.2 mg/l and 0.4 mg/l groups. However, femoral bone mineral density (BMD) values in the WF-treated groups were almost the same as those in the intact group. In experiment 2, we evaluated changes in bone OC levels 4 weeks after discontinuing an 8-week WF treatment. Four-week-old male rats received 0.8 mg/l WF as drinking water for 8 or 12 weeks. Recovery of the OC level after discontinuing the WF treatment was shown in the femoral metaphysis, but not in the diaphysis. In experiment 3, 0.3 mg/kg WF was administrated to 25-week-old male rats three times a week for 8, 12, or 16 weeks. In aged rats, decreased bone OC was shown in the femoral metaphysis, but not in the diaphysis. From these findings, it is suggested that the effects of WF on gamma-carboxylation are likely to appear in bone at lower doses than in the liver, that the bone OC level does not always correspond directly to plasma GlaOC, and that the bone OC level is not directly linked with BMD.
The future of blood services amid a tight balance between the supply and demand of blood products: Perspectives from the ISBT Young Professional Council

Antoine Lewin,Eunike McGowan,Jian Ou‐Yang,Lilian Antwi Boateng,Carla Luana Dinardo,Saikat Mandal,Nour Almozain,Jannison Ribeiro,Syeldy Langi Sasongko,the Young Professional Council of the ISBT

DOI: https://doi.org/10.1111/vox.13590

2024-01-27

Vox Sanguinis

Abstract:Background and Objectives Blood services manage the increasingly tight balance between the supply and demand of blood products, and their role in health research is expanding. This review explores the themes that may define the future of blood banking. Materials and Methods We reviewed the PubMed database for articles on emerging/new blood‐derived products and the utilization of blood donors in health research. Results In high‐income countries (HICs), blood services may consider offering these products: whole blood, cold‐stored platelets, synthetic blood components, convalescent plasma, lyophilized plasma and cryopreserved/lyophilized platelets. Many low‐ and middle‐income countries (LMICs) aim to establish a pool of volunteer, non‐remunerated blood donors and wean themselves off family replacement donors; and many HICs are relaxing the deferral criteria targeting racial and sexual minorities. Blood services in HICs could achieve plasma self‐sufficiency by building plasma‐dedicated centres, in collaboration with the private sector. Lastly, blood services should expand their involvement in health research by establishing donor cohorts, conducting serosurveys, studying non‐infectious diseases and participating in clinical trials. Conclusion This article provides a vision of the future for blood services. The introduction of some of these changes will be slower in LMICs, where addressing key operational challenges will likely be prioritized.

hematology
International blood collection and storage: Clinical use of blood products

David W. Greening,Kristen M. Glenister,Rosemary L. Sparrow,Richard J. Simpson

DOI: https://doi.org/10.1016/j.jprot.2009.07.011

IF: 3.855

2010-01-01

Journal of Proteomics

Abstract:Human blood transfusion is the process of transferring blood or blood-based products from an individual into the circulatory system of another. From the theory of circulation of blood to the early practice of blood transfusion, transfusion medicine has been an important concept for many centuries. The practicality of transfusion, however, only became a possibility during and shortly after the Second World War. Today, blood and its derivatives play a critical role in worldwide health care systems, with blood components having direct clinical indications. Over the past several years worldwide organizations including the World Health Organization (WHO) have made a number of substantial improvements to the regulation of the worlds blood supply. This continuous supply plays a critical role throughout health care systems worldwide, with procedures for blood collection, processing, and storage now complex, standardised processes. As the areas of clinical validation of different disease states from blood-derived sources (i.e., disease biomarkers) move towards validation stages, the importance of controlled- and standardised-protocols is imperative.

biochemical research methods
The role and importance of epidemiology in transfusion medicine

Constantina Politis,Tomislav Vuk,Clive Richardson,Lida Politi,Olivier Garraud

DOI: https://doi.org/10.1016/j.tracli.2024.01.004

IF: 2.126

2024-01-13

Transfusion Clinique et Biologique

Abstract:Transfusion therapy is an indispensable form of treatment, and an important element of the public health system. Due to its origin, blood's clinical use is associated with various risks that may cause adverse reactions and events. Progress in quality and safety of blood components has eliminated numerous risks, especially those of infectious origin. However, some risks cannot be predicted, while others cannot always be prevented. Globalisation and climate change constantly favour the spread of infectious agents. Against this, epidemiology plays a central role in ensuring the safety of transfusion treatment, by continuous surveillance and timely identification of risks, and in the development of routine and additional tests as measures for risk mitigation. As a quantitative discipline based on research methods, epidemiology is a method of reasoning; it relies on the generation and testing of hypotheses; it utilises other scientific resources, particularly in the field of blood donation and blood transfusion, thus having many applications. The main focus falls on transfusion-transmissible infections, and on environmental or occupational diseases, injuries, disabilities and death causes at large. The practice of epidemiology relies on a systematic approach and measurement of disease frequencies. Surveillance is a key element, involving continuously gathering, analysing, and evaluating data regarding diseases, morbidity and mortality, and disseminating the conclusions of the analyses to relevant competent authorities; in this way, action is taken for disease prevention and control. Surveillance systems also provide an important tool for risk assessment, a method to assess and characterise the critical parameters in the functionality of equipment, systems or processes of using scientific data in order to estimate the magnitude of any health effect that derives from decisions of policy makers. Epidemiological surveillance, particularly for the incidence of adverse reactions and adverse events associated with blood transfusion at the national and international levels, has demonstrated the importance of multidisciplinary cooperation between blood and public health services.

immunology,hematology
Transfusion practice and safety: current status and possibilities for improvement

M. F. Murphy,S. J. Stanworth,M. Yazer

DOI: https://doi.org/10.1111/j.1423-0410.2010.01366.x

2010-12-22

Vox Sanguinis

Abstract:Audits of practice and incident reporting, most notably to national haemovigilance schemes, indicate that poor hospital transfusion practice is frequent and occasionally results in catastrophic consequences for patients. Improvements in practice are needed and depend on a combined approach including a better understanding of the causes of errors; a reduction in the complexity of routine procedures taking advantage of new technology systems, which enforce agreed guidelines and policies; the setting and regular monitoring of performance standards for key aspects of the hospital transfusion process, improved organisation of transfusion in hospitals and staff training; and further research on the safe and effective use of blood and alternatives to donor blood. There needs to be a greater recognition that 'transfusion safety' applies to the hospital transfusion process as well as the contents of blood bags and that resources need to be provided for the improvement of transfusion safety and management in hospitals commensurate to their importance.

hematology
Evaluation of two acute cardiac ischemia decision-support tools in a rural family practice.

L. Green,M. Smith

Journal of family practice

Abstract:This study investigated the applicability in a primary care setting of two decision-support tools for evaluating the necessity of admitting patients with suspected acute cardiac ischemic disease to a cardiac intensive care unit. The heart disease predictive instrument (HDPI) of Pozen et al and the electrocardiogram scoring method of Brush et al were applied to records from all patients with cardiac-related diagnoses admitted to a family practice service. A retrospective review of medical records of all patients admitted with suspected acute ischemic heart disease to a rural community hospital family practice service was conducted. Of 147 patients identified, 108 were admitted primarily for suspected ischemia. Twenty-four myocardial infarctions occurred among these 108 patients (22.2 percent). Patients with HDPI probabilities of less than 50 percent were very unlikely to sustain infarction and in no case required intensive intervention for any problem not apparent at admission. Only 15 instances of the four types of complications that the instrument of Brush et al is designed to predict occurred; this incidence was too low to allow statistical testing. In summary, the heart disease predictive instrument reliably identified patients unlikely to require intensive care services in this population. Because of the low incidence of complications in this population, the instrument described by Brush et al was not found to be clinically useful.
[Transfusiology knowledge and competence of nurses in light of a national survey]

Veronika Rajki,Mária Csóka,Tibor Deutsch,Judit Mészáros

DOI: https://doi.org/10.1556/650.2015.30227

2015-08-23

Abstract:Introduction: International literature data clearly show that the role of nurses in transfusion therapy, which needs professional knowledge and skills, continues to increase. Aim: The aim of the authors was to perform a national-level mapping of the practice of transfusion therapy including transfusion therapy-related knowledge of nurses and their knowledge about their competence. Further aim was to identify similarities and differences as referred to the requirements of the transfusion regulations (2008), which was valid at the time of the survey in Hungary. Method: The nationwide survey took place between November 19, 2014 and February 20, 2015. Data were collected using paper-form and web-based anonymous, self-administered questionnaire. 657 nurses who were involved in transfusion therapy with changing regularity in adult in-patient wards took part in the survey. Data were processed using descriptive statistical methods. Results: It was found that the transfusion therapy related knowledge of nurses was very incomplete (50.72%), and only about half of the nurses (52.3%) systematized the nursing functions correctly. Significant differences were also found in the practice of transfusion therapy. The vast majority of the institutions had their own protocol, but responsible nurses assigned for transfusion care were present only in 23.9% of the wards. Conclusions: The authors conclude that the identified problems can be resolved by improving professional responsibility of nurses, increasing supervision by nursing leaders and appropriate transfusiology training and regular retrainings.
A survey of blood component use in a German university hospital

R Zimmermann,M Büscher,C Linhardt,D Handtrack,J Zingsem,V Weisbach,R Eckstein,M Buscher

DOI: https://doi.org/10.1046/j.1537-2995.1997.371098016449.x

1997-10-01

Transfusion

Abstract:BACKGROUND: There are no recent studies on transfusion practice and blood use with regard to diagnoses of European recipients. We conducted a survey of blood component use, including packed red cells, fresh-frozen plasma, and platelets, in an acute-care university hospital in the Greater Nürnberg area.STUDY DESIGN AND METHODS: A survey was carried out of blood component transfusion at a university hospital (Erlangen, Germany) between June 1994 and May 1996. Transfused units were listed by broad diagnostic categories formed from principal diagnoses of the recipients according to the International Classification of Diseases, Ninth Revision.RESULTS: Among 100,497 discharged patients, 6,590 patients who received transfusion (6.6%) are represented in this survey. Of 28,440 red cell units and 8,592 fresh-frozen plasma units, 72.4 percent and 66.9 percent, respectively, were used in patients with neoplastic diseases, circulatory system diseases, or disorders of the digestive system. Of 2704 platelet units, 78.1 percent were transfused to patients with neoplastic or gastrointestinal diseases or diseases of blood-forming organs. These four diagnostic categories accounted for 77.7 percent of all costs of transfusion therapy. Males received 60.1 percent of all blood components transfused, and patients less than 65 years old received 68.0 percent.CONCLUSION: This survey provides information on blood component usage in a German university hospital. It demonstrates the concentration of today's blood utilization among a few diagnostic categories. The study shows that detailed information on local blood use may be obtained quickly by using data available from transfusion services and medical record departments. This information is relevant for quality management of transfusion practice, cost analyses and for planning local and regional blood donation programs.

hematology
International issues in transplantation. Setting the scene and flagging the most urgent and controversial issues

B Miranda,R Matesanz

DOI: https://doi.org/10.1111/j.1749-6632.1998.tb09126.x

1998-12-30

Abstract:Organ transplantation is the primary technique for treatment of end-stage organ failure and has benefited more than one million persons world wide. A number of patients have survived for well over 25 years and survival rates at 5 years can be 70% or higher for many organ transplant programs. However, currently more than 40,000 patients are waiting for a kidney, and in western Europe mortality rates for patients waiting for a heart, liver, or lung range from 15 to 30%. The potential need for transplants is even greater and this imbalance between supply and demand creates technical and ethical problems including the risk of organ trafficking. Consequently the number of available organs must be increased. In some cases the organ shortage reflects a true lack of donors, but more often it results from the failure to turn potential into actual donors. The transplant commission of the Council of Europe has just approved a document recommending that member states ensure that all potential donors are identified and as many as possible converted to actual donors. Even with the highest organ donation rate, the indications for organ and tissue transplantation will continue to increase, perpetuating the gap between supply and demand. Organ transplantation, whether living or cadaveric, might be supplemented or replaced by the use of artificial organs, although problems such as power supply, thrombosis, infection, and biocompatibility pose obstacles to long-term function. The use of animals as an alternative source is considered, but so many problems still remain unresolved that xenotransplantation cannot be put forth as a solution at this time. This paper reviews these issues and, citing the Spanish experience, offers strategies to improve the organ donation rate.
Organ donation and transplantation: a multi-stakeholder call to action

Raymond Vanholder,Beatriz Domínguez-Gil,Mirela Busic,Helena Cortez-Pinto,Jonathan C. Craig,Kitty J. Jager,Beatriz Mahillo,Vianda S. Stel,Maria O. Valentin,Carmine Zoccali,Gabriel C. Oniscu

DOI: https://doi.org/10.1038/s41581-021-00425-3

IF: 42.439

2021-05-05

Nature Reviews Nephrology

Abstract:Although overall donation and transplantation activity is higher in Europe than on other continents, differences between European countries in almost every aspect of transplantation activity (for example, in the number of transplantations, the number of people with a functioning graft, in rates of living versus deceased donation, and in the use of expanded criteria donors) suggest that there is ample room for improvement. Herein we review the policy and clinical measures that should be considered to increase access to transplantation and improve post-transplantation outcomes. This Roadmap, generated by a group of major European stakeholders collaborating within a Thematic Network, presents an outline of the challenges to increasing transplantation rates and proposes 12 key areas along with specific measures that should be considered to promote transplantation. This framework can be adopted by countries and institutions that are interested in advancing transplantation, both within and outside the European Union. Within this framework, a priority ranking of initiatives is suggested that could serve as the basis for a new European Union Action Plan on Organ Donation and Transplantation.

urology & nephrology
A national surveillance system for continuous monitoring of blood transfusion safety: German haemovigilance data

Philipp Berg,Margarethe Heiden,Susanne Müller,Britta Meyer,Cornelia Witzenhausen,Gabriele Ruppert‐Seipp,Sarah Kehr,Markus B. Funk

DOI: https://doi.org/10.1111/vox.13694

2024-06-20

Vox Sanguinis

Abstract:Background and Objectives Haemovigilance (HV) systems aim to improve transfusion outcomes in patients and donor safety. An important question for blood regulators is how to ensure an effective HV system. Materials and Methods We retrospectively analysed the HV reports submitted to Paul‐Ehrlich‐Institut over the last two decades. Results Between 2011 and 2020, 50.86 million units of blood components were used, and 8931 suspected serious donor and recipient adverse reactions (SARs), 874 serious adverse events (SAEs) and 12,073 donor look‐backs were reported. Following implementation of specific risk‐minimization measures (RMMs) between 2000 and 2010, SAR reporting rates decreased for transfusion‐transmitted viral infections (TTVIs), transfusion‐related acute lung injury (TRALI) and transfusion‐transmitted bacterial infections (TTBIs), while increasing for other serious adverse transfusion reactions. Within this decade, the overall blood component use decreased. Conclusion Long‐term data collection forms the basis to establish trends and changes in reporting and to evaluate the effect of RMM. Standardized criteria for reaction types, seriousness and imputability assessments and availability of a denominator are important elements. Central data collection and independent assessment allow for monitoring HV data in a nationwide context over time. Stakeholder involvement and transparent feedback on the benefit of RMM will help to achieve the objectives of HV.

hematology
Red Blood Cell Transfusion in European Neonatal Intensive Care Units

Nina A. M. Houben,Suzanne Fustolo-Gunnink,Karin Fijnvandraat,Camila Caram-Deelder,Marta Aguar Carrascosa,Alain Beuchée,Kristin Brække,Francesco Cardona,Anne Debeer,Sara Domingues,Stefano Ghirardello,Ruza Grizelj,Emina Hadžimuratović,Christian Heiring,Jana Lozar Krivec,Jan Malý,Katarina Matasova,Carmel Maria Moore,Tobias Muehlbacher,Miklos Szabó,Tomasz Szczapa,Gabriela Zaharie,Justine de Jager,Nora Johanna Reibel-Georgi,Helen V. New,Simon J. Stanworth,Emöke Deschmann,Charles C. Roehr,Christof Dame,Saskia le Cessie,Johanna van der Bom,Enrico Lopriore,International Neonatal Transfusion Point Prevalence Study Group,Miguel Alsina-Casanova,Ola Andersson,Rosa Patricia Arias-Llorente,Adeline Berenger,Edyta Bielska,Marioara Boia,André Birkenmaier,Jakub Biros,Anne Laure Blanquart,Tiziana Boggini,Pascal Boileau,Renata Bokiniec,Ilia Bresesti,Katherine Broad,Giacomo Cavallaro,Jennifer Chauvel,Borbála Cseszneki,Carlo Dani,Klaudia Demová,Diana Dornis,Marie-Pierre Duban,Karolina Dziadkowiec-Motyl,Nika Erzen,Eszter Fanczal,Sara Fernández-Castiñeira,Libusa Galuschka,Ellen Gandaputra,Fermín García-Muñoz Rodrigo,Corinna Gebauer,Hélène Grimault,Kristina Grund,Melanie Gsöllpointner,Silvia Gualdi,Brunetta Guaragni,Markus Hahn,Nadja Haiden,Monica Hasmasanu,Daniela Iacob,Mihaela Ivanici,Raphaela Jernej,Tomáš Juren,Karolina Karcz,Lilijana Kornhauser,Barbara Królak-Olejnik,Lena Legnevall,Verena Lehnerer,Emmanuelle Levine,María Del Carmen López Castillo,Mariella Magarotto,Silvia Martini,Iwona Maruniak-Chudek,Rita Moita,Anjola Mosuro,Agnieszka Nowicka,Daniel O'Reilly,Manuela Pantea,Alejandro Pérez-Muñuzuri,Tina Perme,Laura Picciau,Sandra Prins,Maurizio Radicioni,Genny Raffaeli,Reyes Roldan-López,Jean-Michel Roué,Beata Rzepecka Węglarz,Greta Sibrecht,Pauline Snijder,Mirta Starčević,Emese Szántó,Liliana Teixeira,Laura Torrejon,Lourdes Urquía Martí,Laurien Vanbuggenhout,Lorenzo Zanetto

DOI: https://doi.org/10.1001/jamanetworkopen.2024.34077

2024-09-20

JAMA Network Open

Abstract:Importance Red blood cell (RBC) transfusions are frequently administered to preterm infants born before 32 weeks of gestation in the neonatal intensive care unit (NICU). Two randomized clinical trials (Effects of Transfusion Thresholds on Neurocognitive Outcomes of Extremely Low-Birth-Weight Infants [ETTNO] and Transfusion of Prematures [TOP]) found that liberal RBC transfusion thresholds are nonsuperior to restrictive thresholds, but the extent to which these results have been integrated into clinical practice since publication in 2020 is unknown. Objective To describe neonatal RBC transfusion practice in Europe. Design, Setting, and Participants This international prospective observational cohort study collected data between September 1, 2022, and August 31, 2023, with a 6-week observation period per center, from 64 NICUs in 22 European countries. Participants included 1143 preterm infants born before 32 weeks of gestation. Exposure Admission to the NICU. Main Outcomes and Measures Study outcome measures included RBC transfusion prevalence rates, cumulative incidence, indications, pretransfusion hemoglobin (Hb) levels, volumes, and transfusion rates, Hb increment, and adverse effects of RBC transfusion. Results A total of 1143 preterm infants were included (641 male [56.1%]; median gestational age at birth, 28 weeks plus 2 days [IQR, 26 weeks plus 2 days to 30 weeks plus 2 days]; median birth weight, 1030 [IQR, 780-1350] g), of whom 396 received 1 or more RBC transfusions, totaling 903 transfusions. Overall RBC transfusion prevalence rate during postnatal days 1 to 28 was 3.4 transfusion days per 100 admission days, with considerable variation across countries, only partly explained by patient mix. By day 28, 36.5% (95% CI, 31.6%-41.5%) of infants had received at least 1 transfusion. Most transfusions were given based on a defined Hb threshold (748 [82.8%]). Hemoglobin levels before transfusions indicated for threshold were below the restrictive thresholds set by ETTNO in 324 of 729 transfusions (44.4%) and TOP in 265 of 729 (36.4%). Conversely, they were between restrictive and liberal thresholds in 352 (48.3%) and 409 (56.1%) transfusions, respectively, and above liberal thresholds in 53 (7.3%) and 55 (7.5%) transfusions, respectively. Most transfusions given based on threshold had volumes of 15 mL/kg (470 of 738 [63.7%]) and were administered over 3 hours (400 of 738 [54.2%]), but there was substantial variation in dose and duration. Conclusions and Relevance In this cohort study of very preterm infants, most transfusions indicated for threshold were given for pretransfusion Hb levels above restrictive transfusion thresholds evaluated in recent trials. These results underline the need to optimize practices and for implementation research to support uptake of evidence.

medicine, general & internal
The global need and availability of blood products: a modelling study

Nicholas Roberts,Spencer James,Meghan Delaney,Christina Fitzmaurice

DOI: https://doi.org/10.1016/s2352-3026(19)30200-5

IF: 30.153

2019-12-01

The Lancet Haematology

Abstract:<h2 class="section-title u-h3 u-margin-l-top u-margin-xs-bottom">Summary</h2><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Blood transfusions are an important resource of every health-care system, with often limited supply in low-income and middle-income countries; however, the degree of unmet need for blood transfusions is often unknown. We therefore aimed to estimate the blood transfusion need and supply at national level to determine gaps in transfusion services globally.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>We did a modelling study involving 195 countries and territories. We used blood component preparation data from 2011–13 to estimate blood availability for 180 (92%) of 195 countries from the WHO Global Status Report on Blood Safety and Availability. We calculated disease-specific transfusion needs per prevalent case for 20 causes in the USA using the National (Nationwide) Inpatient Sample dataset between the years 2000 and 2014, and the State Inpatient Databases between 2003 and 2007 from the Healthcare Cost and Utilization Project. Using prevalence estimates for the USA from the Global Burden of Disease (GBD) 2017 study, we estimated the ideal disease specific-transfusion rate as the lowest rate from the years 2000 to 2014. We applied this rate to GBD prevalence results for 195 countries to estimate transfusion needs. Unmet need was the difference between the estimated supply and need.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Findings</h3><p>In 2017, the global blood need was 304 711 244 (95% uncertainty interval [UI] 293 064 637–314 049 479) and the global blood supply was 272 270 243 (268 002 639–276 698 494) blood product units, with a need-to-supply ratio of 1·12 (95% UI 1·07–1·16). Of the 195 countries, 119 (61%) did not have sufficient blood supply to meet their need. Across these 119 countries, the unmet need totalled 102 359 632 (95% UI 93 381 710–111 360 725) blood product units, equal to 1849 (1687–2011) units per 100 000 population globally. Every country in central, eastern, and western sub-Saharan Africa, Oceania, and south Asia had insufficient blood to meet their needs.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Interpretation</h3><p>Our data suggest that the gap between need and supply is large in many low-income and middle-income countries, and reinforce that the WHO target of 10–20 donations per 1000 population is an underestimate for many countries. A continuous expansion and optimisation of national transfusion services and implementation of evidence-based strategies for blood availability is needed globally, as is more government support, financially, structurally, and through establishment of a regulatory oversight to ensure supply, quality, and safety in low-income and middle-income countries.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Funding</h3><p>National Institutes of Health.</p>
Transfusion strategies in non-bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine

Alexander P. Vlaar,Simon Oczkowski,Sanne de Bruin,Marije Wijnberge,Massimo Antonelli,Cecile Aubron,Philippe Aries,Jacques Duranteau,Nicole P. Juffermans,Jens Meier,Gavin J. Murphy,Riccardo Abbasciano,Marcella Muller,Akshay Shah,Anders Perner,Sofie Rygaard,Timothy S. Walsh,Gordon Guyatt,J. C. Dionne,Maurizio Cecconi

DOI: https://doi.org/10.1007/s00134-019-05884-8

IF: 38.9

2020-01-07

Intensive Care Medicine

Abstract:<h3 class="Heading">Objective</h3><p class="Para">To develop evidence-based clinical practice recommendations regarding transfusion practices in non-bleeding, critically ill adults.</p><h3 class="Heading">Design</h3><p class="Para">A task force involving 13 international experts and three methodologists used the GRADE approach for guideline development.</p><h3 class="Heading">Methods</h3><p class="Para">The task force identified four main topics: red blood cell transfusion thresholds, red blood cell transfusion avoidance strategies, platelet transfusion, and plasma transfusion. The panel developed structured guideline questions using population, intervention, comparison, and outcomes (PICO) format.</p><h3 class="Heading">Results</h3><p class="Para">The task force generated 16 clinical practice recommendations (3 strong recommendations, 13 conditional recommendations), and identified five PICOs with insufficient evidence to make any recommendation.</p><h3 class="Heading">Conclusions</h3><p class="Para">This clinical practice guideline provides evidence-based recommendations and identifies areas where further research is needed regarding transfusion practices and transfusion avoidance in non-bleeding, critically ill adults.</p>

critical care medicine

Nonconjugate adaptation of human saccades to anisometropic spectacles: Meridianspecificity

Effect of endodontic cement on bone mineral density using serial dual-energy x-ray absorptiometry.

Quality management in blood establishments

Blood and Blood Components: From Similarities to Differences

Transfusion in limited infrastructure locations – where to go decades after safe blood initiative by World Health Organization?

Quality Assessment of Established and Emerging Blood Components for Transfusion

Roles of thyroid, adrenal and pancreatic hormones on thyroid activity of the soft-shelled turtles Lissemys punctata punctata Bonnoterre.

Comparison of inhibitory effects of warfarin on gamma-carboxylation between bone and liver in rats.

The future of blood services amid a tight balance between the supply and demand of blood products: Perspectives from the ISBT Young Professional Council

International blood collection and storage: Clinical use of blood products

The role and importance of epidemiology in transfusion medicine

Transfusion practice and safety: current status and possibilities for improvement

Evaluation of two acute cardiac ischemia decision-support tools in a rural family practice.

[Transfusiology knowledge and competence of nurses in light of a national survey]

A survey of blood component use in a German university hospital

International issues in transplantation. Setting the scene and flagging the most urgent and controversial issues

Organ donation and transplantation: a multi-stakeholder call to action

A national surveillance system for continuous monitoring of blood transfusion safety: German haemovigilance data

Red Blood Cell Transfusion in European Neonatal Intensive Care Units

The global need and availability of blood products: a modelling study

Transfusion strategies in non-bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine